Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYR-PB21 for postoperative analgesia after arthroscopic rotator cuff repair (phase 2)
CTR20234143Phase 2Active
- Sponsor
- Hefei Cosource Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HYR-PB21 in postoperative pain, sponsored by Hefei Cosource Pharmaceutical. Started Jan 2024; status: active.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20234143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234143.